Michael Schopis
Gastroenterology · New York, NYNPI 1386175123
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 32.0% of the total. 2025 is the largest year on record at $4,828, 2.5 times the $1,967 reported in 2023.
Across 397 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- AbbVie$1K
- Johnson & Johnson$1K
- Celltrion USA Inc.$532
- QOL Medical, LLC$460
- Pfizer$442
- plus $3K from 16 others
What the payments were for
- Food & beverage$9,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 159 | $3,169 |
| AbbVie | 59 | $1,475 |
| Johnson & Johnson | 43 | $1,063 |
| Celltrion USA Inc. | 19 | $532 |
| QOL Medical, LLC | 11 | $460 |
| Pfizer | 22 | $442 |
| Sanofi | 3 | $423 |
| Regeneron Healthcare Solutions, Inc. | 7 | $390 |
| Ardelyx, Inc. | 17 | $388 |
| Redhill Biopharma Inc. | 12 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $199 |
| Lilly USA, LLC | 3 | $162 |
| Phathom Pharmaceuticals, Inc. | 8 | $160 |
| Ironwood Pharmaceuticals, Inc | 7 | $149 |
| Bristol Myers Squibb | 6 | $114 |
| Conmed Corporation | 1 | $102 |
| Braintree Laboratories, Inc. | 4 | $101 |
| Olympus America Inc. | 1 | $100 |
| Ipsen Biopharmaceuticals, Inc | 3 | $79 |
| Exact Sciences | 2 | $53 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Galderma Laboratories, L.p. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$673
- XIFAXAN$392
- Skyrizi$275
- Sucraid$145
- OMVOH$125
- CONMED BILIARY$102
- CONMED GENERATORS$102
- VISIGLIDE$100
How this compares
$9,889 in reported general payments places this provider in the 80th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.